IFNB1 and myeloid sarcoma: As will be explained later, IFNβ suppresses inflammatory responses in MS patients by four major mechanisms, including blocking T cell activation, controlling pro- and anti-inflammatory cytokine secretion, preventing activated immune cell migration through BBB, and inducing repair activity of damaged nerve cells by differentiating neural stem cells into oligodendrocytes.3, 5, 16